Ireland
--:--IST
Latest
Clinical Trials in France / NCT06262009
Recruiting Observational

Dynamics of AMR Spread, Persistence and Evolution Between Humans, Animals and Their Environment

NCT06262009 · tracked via the Priya Life Science France tracker
Phase
Observational
Started
2025-12-15
Last updated
2026-04-23

Condition(s) studied

Antibiotic Resistant StrainTransmission, Close-Contact

Investigational drug(s) / intervention(s)

human faecal collectionancillary study

human faecal collection: collecting stools 6 times over a 90 days period and complete a questionnaire at the same times: D1, D7, D15, D30, D60 and D90

ancillary study: interviews and/or ethnographic observations for 50 volunteers

Study summary

Humans in contact with animals such as dog owners, may be at risk of antimicrobial resistance (AMR) acquisition. This is the central issue to be investigated in DYASPEO

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Adult or child planning to live in the same household as his/her dog during the three months following inclusion. * Planning to live in the same habitat in the next three months following inclusion (except for holidays). * Written consent of all adults and of at least one of the two parents for minors under parental authority. A different information note will be elaborated for each age category (6-10 yr-old, 10-15 yr-old and 16-18 yr-old). * Owning a dog recorded for a surgery at the National Veterinary School Exclusion Criteria: * Lack of signed informed consent * Subject in alternating custody * Subject under legal protection (guardianship) * Subject deprived of liberty under judicial constraint * Subject undergoing psychiatric care * Lack of affiliation to a social security scheme * Volunteers who do not speak/write French

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
the National Veterinary School Alfort Maisons-Alfort France Recruiting

More Assistance Publique - Hôpitaux de Paris trials in France

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06262009 on ClinicalTrials.gov ↗ ← All trials in France